Obesity and Inflammation and Altered Clopidogrel Pharmacokinetics and Pharmacodynamics

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|11|1|3-13

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.11, Iss.1, 2017-11, pp. : 3-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

No Influence of Obesity on the Pharmacokinetics and Pharmacodynamics of Melagatran, the Active Form of the Oral Direct Thrombin Inhibitor Ximelagatran

By Sarich T.C.  

Clinical Pharmacokinetics, Vol. 42, Iss. 5, 2003-01 ,pp. : 485-492

Adis International

Access to resources Recommend Favorite

Effect of Orlistat, a Novel Anti-Obesity Agent, on the Pharmacokinetics and Pharmacodynamics of Pravastatin in Patients with Mild Hypercholesterolaemia

By Oo C.Y.   Akbari B.   Lee S.   Nichols G.   Hellmann C.P.  

Clinical Drug Investigation, Vol. 17, Iss. 3, 1999-03 ,pp. : 217-223

Adis International

Access to resources Recommend Favorite

Volterra Series in Pharmacokinetics and Pharmacodynamics

By Verotta Davide  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 30, Iss. 5, 2003-10 ,pp. : 337-362

Springer Publishing Company

Access to resources Recommend Favorite

Ocular pharmacokinetics/pharmacodynamics

By Worakul N.   Robinson J.R.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 44, Iss. 1, 1997-07 ,pp. : 71-83

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Pegfilgrastim

By Yang Bing-Bing   Kido Anna  

Clinical Pharmacokinetics, Vol. 50, Iss. 5, 2011-05 ,pp. : 295-306

Adis International

Access to resources Recommend Favorite